Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics-Reference-Cited by-同舟云学术

Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics

Published:2013-11-25 Issue:4 Volume:19 Page:217-224
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Konialis Christopher¹,Savola Suvi²,Karapanou Sophia¹,Markaki Aggeliki¹,Karabela Maria¹,Polychronopoulou Sophia³,Ampatzidou Maria³,Voulgarelis Michael⁴,Viniou Nora-Athina⁵,Variami Eleni⁵,Koumarianou Argyro⁶,Zoi Katerina⁷,Hagnefelt Birgitta¹,Schouten Jan P.²,Pangalos Constantinos¹

Affiliation:

1. InterGenetics – Diagnostic Genetic CenterAthens, Greece

2. MRC-HollandAmsterdam, The Netherlands

3. Department of Paediatric Haematology-Oncology‘Aghia Sophia’ Children's Hospital, Athens, Greece

4. Pathophysiology DepartmentSchool of Medicine, University of Athens, Athens, Greece

5. 1st Pathology ClinicUniversity of Athens, Laiko Hospital, Athens, Greece

6. ‘IASO General’ Hospital Athens, Greece

7. Haematology Research LaboratoryBiomedical Research Foundation, Academy of Athens, Athens, Greece

Publisher

Informa UK Limited

Subject

Hematology,Hematology